Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

Table 2 Key insulin treatment related endpoints of patients on insulin detemir and insulin glargine at final visit: SOLVE™ Turkish cohort (mean ± SD)

	Insulin detemir	Insulin glargine
HbA_1c (%)	7.48 ± 1.19	7.38 ± 1.24
HbA_1c (mmol/mol)	58 ± 13	57 ± 14
FBG (mg/dl)	145 ± 44	139 ± 38
FBG (mmol/l)	8.0 ± 2.4	7.7 ± 2.1
Weight (kg)	79.5 ± 12.6	79.7 ± 12.2
Rate of Minor Hypoglycaemia (events ppy)	1.08	2.56
Insulin Dose (U/kg)	0.30 ± 0.13	0.31 ± 0.14

ISSN: 1472-6823